Goodwin advised Rubius Therapeutics on the closing of its initial public offering of 12,055,450 shares of common stock at a public offering price of $23.00 per…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now